|
CPhI Japan returns to Tokyo from April 19-21, 2017
|
|
Our Bureau, Mumbai
March 29 , 2017
|
|
|
CPhI Japan, organised by UBM EMEA and UBM Japan, will be returning to
the Tokyo Big Sight Centre for its 16th edition from the April 19-21,
2017. Gathering over 19,600 attendees and 550 exhibitors from 30
countries, the show will co-locate with ICSE, P-MEC, BioPh, and
InnoPack. An ageing population, a growing generics market and
liberalization of Over-The-Counter medicines make Japan an attractive
destination for investments, particularly as the pharma industry
undergoes legislative change, with the Government¹s bid to cut
healthcare expenditure.
Central to the internationalisation of
the Japanese market is CPhI Japan, which returns as the most
comprehensive pharma event in the region to provide the latest trends,
insights and innovations in the industry. The five-in-one event allows
visitors to gain access to the entire Japanese pharma industry under one
roof, and meet with exhibitors working across ingredients, contract
services, biopharmaceuticals, machinery, technology, and packaging.
Japan
is the world's third largest pharma industry, with a market that is
forecasted to reach a total value of US$ 115 billion by 2024. However,
due to an ageing population and growing healthcare costs, the Government
recently committed to increase market penetration of generics from 30
per cent in 2014, to 60 per cent by the end of this year. The surge in
demand will open up new opportunities for international pharmaceutical
manufacturers, as domestic producers alone will struggle to meet
required capacity. High quality Indian generic manufacturers and branded
generics, particularly those from the United States and Europe, are
well placed to expand market share.
To help explore the market's
potential, running alongside the exhibition is a three-day, in-depth
conference. CPhI Japan's high-value conference programme enables
attendees to learn about the latest trends and strategies in the market.
It features bespoke content discussions and special seminars across
topics such as An Evolving Pharma Market - Challenges and Opportunities
Ahead - Outlook to 2021, and Digital health: What does it mean exactly?.
Additionally,
keynote sessions will address current situations and challenges of
policy on health insurance and current topics regarding regulation of
pharmaceuticals in Japan. Finally, an important session, dedicated to
the new pricing and reimbursement system of medicines set in December
2016, will discuss the effects this will have in the market, including
the potential reduction in overall prices and increased competition.
Other
notable features at CPhI Japan 2017 include: The Customer Insights
Lounge enables attendees to interact with CPhI Japan personnel and
gather insights about the pharmaceutical market, company developments,
and share event experiences.
The renowned Business Matchmaking
Programme, an online matchmaking tool, enables attendees to search for
and arrange meetings with exhibitors prior to the show.
Exhibitor
Showcases will run on the show floor and allow exhibitors 30-minutes to
present their products, services, new launches, and innovations to
visitors and press.
For more information about CPhI Japan,visit http://www.cphi.com/japan
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|